ArticleRheumatology and therapy2019

Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study.

Alan J Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.